Literature DB >> 31485699

What is the Significance of Elevated Troponin I in Children and Adolescents? A Diagnostic Approach.

Tamer Yoldaş1,2, Utku Arman Örün3.   

Abstract

Troponin is a marker that displays cardiac injury quickly and accurately. In adults, troponin elevation is usually associated with coronary artery disease and requires urgent cardiac catheterization. In healthy children, myocardial injury is rare and may develop due to many different causes. Therefore, troponin elevation in children and adolescents does not usually require emergency cardiac catheterization. The aim of this study is to assess the most common causes of troponin elevation in children and adolescents and to show which diagnostic tests are helpful in assessing pediatric patients with elevated troponin. Patients who had been diagnosed with troponin I elevation (> 0.06 ng/ml) at Dr. Sami Ulus Maternity, Children's Health and Disease Training and Research Hospital between 2007 and 2018 were retrospectively evaluated. Patients undergoing cardiac surgery and those with severe congenital heart disease were excluded from the study. The medical records of the patients were examined and age, gender, diagnostic tests, and diagnosis were evaluated. During the study period, the records of 972 patients were obtained. 213 patients were excluded from the study because of heart surgery, congenital heart disease, and neonatal asphyxia or sepsis. Of the remaining 759 patients, 58% were male, 42% were female, and the median age was 4 years (3 days to 17 years). The most frequent causes are myopericarditis (n: 164), drug intoxications (n: 85), carbon monoxide poisoning (n: 74), perimyocarditis (n: 65), and intensive inhalation β agonist use in acute asthma and lower respiratory tract infections (n: 70). Patients diagnosed with myocarditis and myopericarditis were admitted with a complaint of chest pain, and the diagnosis was made by history, physical examination, ECG, and echocardiographic findings. Unlike adults, troponin I elevation may be associated with many cardiac and non-cardiac pathologies in children. The most common pathologies in cardiac etiology are myopericarditis and perimyocarditis and can be diagnosed by history, physical examination, ECG, and echocardiography. Cardiac catheterization is not necessary except for rare cardiac pathologies and does not alter the prognosis.

Entities:  

Keywords:  Aetiology; Cardiac; Pediatric; Troponin elevation

Mesh:

Substances:

Year:  2019        PMID: 31485699     DOI: 10.1007/s00246-019-02198-w

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  24 in total

Review 1.  ST-segment elevation in conditions other than acute myocardial infarction.

Authors:  Kyuhyun Wang; Richard W Asinger; Henry J L Marriott
Journal:  N Engl J Med       Date:  2003-11-27       Impact factor: 91.245

2.  Management of pediatric chest pain using a standardized assessment and management plan.

Authors:  Kevin G Friedman; David A Kane; Rahul H Rathod; Ashley Renaud; Michael Farias; Robert Geggel; David R Fulton; James E Lock; Susan F Saleeb
Journal:  Pediatrics       Date:  2011-07-11       Impact factor: 7.124

3.  Electrocardiographic ST-segment elevation: the diagnosis of acute myocardial infarction by morphologic analysis of the ST segment.

Authors:  W J Brady; S A Syverud; C Beagle; A D Perron; E A Ullman; C Holstege; R J Riviello; A Ripley; C A Ghaemmaghami
Journal:  Acad Emerg Med       Date:  2001-10       Impact factor: 3.451

4.  Elevated troponin levels in previously healthy children: value of diagnostic modalities and the importance of a drug screen.

Authors:  Poonam P Thankavel; Arshid Mir; Claudio Ramaciotti
Journal:  Cardiol Young       Date:  2013-03-05       Impact factor: 1.093

5.  Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy.

Authors:  B J Maron; J K Wolfson; S E Epstein; W C Roberts
Journal:  J Am Coll Cardiol       Date:  1986-09       Impact factor: 24.094

6.  Quantitative analysis of narrowings of intramyocardial small arteries in normal hearts, hypertensive hearts, and hearts with hypertrophic cardiomyopathy.

Authors:  M Tanaka; H Fujiwara; T Onodera; D J Wu; M Matsuda; Y Hamashima; C Kawai
Journal:  Circulation       Date:  1987-06       Impact factor: 29.690

7.  Cardiac-specific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes.

Authors:  E M Antman; M J Tanasijevic; B Thompson; M Schactman; C H McCabe; C P Cannon; G A Fischer; A Y Fung; C Thompson; D Wybenga; E Braunwald
Journal:  N Engl J Med       Date:  1996-10-31       Impact factor: 91.245

8.  2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS).

Authors:  Yehuda Adler; Philippe Charron; Massimo Imazio; Luigi Badano; Gonzalo Barón-Esquivias; Jan Bogaert; Antonio Brucato; Pascal Gueret; Karin Klingel; Christos Lionis; Bernhard Maisch; Bongani Mayosi; Alain Pavie; Arsen D Ristic; Manel Sabaté Tenas; Petar Seferovic; Karl Swedberg; Witold Tomkowski
Journal:  Eur Heart J       Date:  2015-08-29       Impact factor: 29.983

9.  Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation.

Authors:  M H M Hessel; D E Atsma; E J M van der Valk; W H Bax; M J Schalij; A van der Laarse
Journal:  Pflugers Arch       Date:  2007-10-02       Impact factor: 3.657

Review 10.  Myopericarditis: Etiology, management, and prognosis.

Authors:  Massimo Imazio; Rita Trinchero
Journal:  Int J Cardiol       Date:  2008-01-24       Impact factor: 4.164

View more
  5 in total

1.  Children diagnosed with coronavirus disease 2019 may have cardiac involvement.

Authors:  Ahmet Sert
Journal:  Pediatr Pulmonol       Date:  2020-07-10

2.  Safety Monitoring of Gene Therapy for Spinal Muscular Atrophy with Onasemnogene Abeparvovec -A Single Centre Experience.

Authors:  Johannes Friese; Stephanie Geitmann; Dorothea Holzwarth; Nicole Müller; Robert Sassen; Ute Baur; Kristin Adler; Janbernd Kirschner
Journal:  J Neuromuscul Dis       Date:  2021

3.  Findings and Outcome of Transcatheter Right Ventricular Endomyocardial Biopsy and Hemodynamic Assessment in Children with Suspected Myocarditis or Cardiomyopathy.

Authors:  Alessia Callegari; Daniel Quandt; Achim Schmitz; Karin Klingel; Christian Balmer; Hitendu Dave; Oliver Kretschmar; Walter Knirsch
Journal:  Int J Environ Res Public Health       Date:  2022-08-21       Impact factor: 4.614

4.  The Evaluation of Troponin I Levels and Myocarditis in Children with COVID-19: A Pediatric Single-Center Experience.

Authors:  Gizem Guner Ozenen; Aybuke Akaslan Kara; Elif Kiymet; Elif Boncuoglu; Sahika Sahinkaya; Ela Cem; Miray Yilmaz Celebi; Pelin Kacar; Mustafa Gulderen; Meltem Uras; Murat Muhtar Yılmazer; Mehmet Murat; Timur Mese; Hasan Agin; Nuri Bayram; İlker Devrim
Journal:  Pediatr Cardiol       Date:  2022-10-09       Impact factor: 1.838

5.  Clinical Trial and Postmarketing Safety of Onasemnogene Abeparvovec Therapy.

Authors:  John W Day; Jerry R Mendell; Eugenio Mercuri; Richard S Finkel; Kevin A Strauss; Aaron Kleyn; Sitra Tauscher-Wisniewski; Francis Fonyuy Tukov; Sandra P Reyna; Deepa H Chand
Journal:  Drug Saf       Date:  2021-08-12       Impact factor: 5.606

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.